Retention of Endogenous Viable Cells Enhances the Anti-Inflammatory Activity of Cryopreserved Amnion
about
Angiogenic Potential of Cryopreserved Amniotic Membrane Is Enhanced Through Retention of All Tissue Components in Their Native State.Grafix(®), a Cryopreserved Placental Membrane, for the Treatment of Chronic/Stalled Wounds.Viable intact cryopreserved human placental membrane for a non-surgical approach to closure in complex wounds.Open surgical implantation of a viable cryopreserved placental membrane after decompression and neurolysis of common peroneal nerve: a case series.In vitro assessment of a novel, hypothermically stored amniotic membrane for use in a chronic wound environment.A prospective, multicentre, open-label, single-arm clinical trial for treatment of chronic complex diabetic foot wounds with exposed tendon and/or bone: positive clinical outcomes of viable cryopreserved human placental membrane.Novel Approach for Enterocutaneous Fistula Treatment with the Use of Viable Cryopreserved Placental MembraneAntimicrobial Peptides Secreted From Human Cryopreserved Viable Amniotic Membrane Contribute to its Antibacterial Activity.Viable placental allograft as a biological dressing in the clinical management of full-thickness thermal occupational burns: Two case reports.Immunomodulatory Effects of Human Cryopreserved Viable Amniotic Membrane in a Pro-Inflammatory Environment In Vitro.The Effect of Cryopreserved Human Placental Tissues on Biofilm Formation of Wound-Associated Pathogens.Use of Viable Cryopreserved Placental Membrane as an Adjunct to Facial Keloid Resection.A comparative outcomes analysis evaluating clinical effectiveness in two different human placental membrane products for wound management.Placental Membranes for Management of Refractory Cutaneous Sinus Tracts of Surgical Origin: A Pilot Study
P2860
Q35927935-86BB1C08-F3B1-4BC7-B6D8-35ADC13D4D72Q35928039-AE4688B7-BFB1-4EB1-9664-3423403EFA51Q38967084-8D9AF095-C3DC-48CB-AB07-C47B58B86F44Q39367354-966F7F83-E499-4716-8B7F-62482690C523Q40266946-B488706F-FAA1-4A68-ADD7-D0F4A14A4B6EQ40589203-C536D850-D90E-4670-846E-76874E933935Q41827358-BB7F5435-A836-483C-A69E-AD9C58FD5EC9Q42652970-A9FD6C81-1F7D-4F45-847B-AD3223DCA9F6Q47158577-09E0F25D-2EB5-40BF-B595-3210E85F4631Q47263559-2B55A326-5DEE-4E19-A2DB-91F13BA16CBFQ48278255-9340DDCB-3FF3-4472-A2DE-A7E825642883Q49724344-EA6533BF-7705-4D7D-B16B-527EB3F3ED87Q53621015-BFA711EC-F377-474C-A850-10C4D805694EQ57152164-D5B2C5A0-F775-4951-9A55-02F175E1AE59
P2860
Retention of Endogenous Viable Cells Enhances the Anti-Inflammatory Activity of Cryopreserved Amnion
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Retention of Endogenous Viable ...... tivity of Cryopreserved Amnion
@ast
Retention of Endogenous Viable ...... tivity of Cryopreserved Amnion
@en
type
label
Retention of Endogenous Viable ...... tivity of Cryopreserved Amnion
@ast
Retention of Endogenous Viable ...... tivity of Cryopreserved Amnion
@en
prefLabel
Retention of Endogenous Viable ...... tivity of Cryopreserved Amnion
@ast
Retention of Endogenous Viable ...... tivity of Cryopreserved Amnion
@en
P2093
P2860
P356
P1476
Retention of Endogenous Viable ...... tivity of Cryopreserved Amnion
@en
P2093
Alexandra Gyurdieva
Alla Danilkovitch
Amy Johnson
Douglas A Jacobstein
Thomas E Uveges
Yi Duan-Arnold
P2860
P304
P356
10.1089/WOUND.2015.0636
P577
2015-09-01T00:00:00Z